Twist Bioscience CFO Adam Laponis Disposes of $1.52M in Shares via Mandated Sell-to-Cover
Twist Bioscience Corp
Subscribe to track TWST
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Twist Bioscience Corp ($TWST) Form 4 Filing Insider: Adam Laponis (Chief Financial Officer) Transaction: Disposed of 8,057 shares at $188.88 per share ($1,521,838.39 total value) Post-Transaction Holdings: 100,576 shares Significance: Low (Non-discretionary sell-to-cover transaction to satisfy tax withholding obligations related to RSU vesting)
Comprehensive Analysis
Overview
On October 5, 2026, Twist Bioscience Corp ($TWST) filed a Form 4 disclosing a transaction by Chief Financial Officer Adam Laponis.
Transaction Summary
- Security: Common Stock
- Transaction Date: October 2, 2026
- Shares Sold: 8,057 shares
- Average Price: $188.884 per share
- Total Gross Proceeds: $1,521,838.39
- Shares Owned After: 100,576 shares (Direct)
Filing Details & Market Context
Footnote disclosures confirm that this disposition was an automatic, non-discretionary "sell to cover" transaction required by the company's equity incentive plans to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
Because this sale was non-discretionary and purely routine tax-related administration, it does not represent an open-market portfolio rebalancing or bearish sentiment by the executive, warranting a Low trading significance classification.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.